A View On Manufacturing Inhaled Drug Products

In late 2022, China introduced the world’s first Covid-19 vaccine to be inhaled into the lungs. But vaccines are just the tip of the inhaler iceberg. A whole range of therapeutic options for many diseases are becoming available through the technology known as dry-powder inhalers, or DPI. Still, getting the correct amount of the molecule to the right part of the lung is tricky business. New manufacturing techniques and new types of molecules make drug inhalers a continually evolving field full of potential advantages for patients.
Listen to this episode of A View On Manufacturing Inhaled Drug Products to learn more about what it takes to develop effective treatments with insights from Lonza’s Associate Director, R&D, Kim Shepard and Matt Ferguson, Lonza’s Head of respiratory drug delivery.

[@tanthiennguyen9308]

Vielen Dank

[@grafixnetz]

For someone who has COPD, and use a CPAP device with humidifier, there MUST be some substance that can be added to the water to deliver some healing directly to the lungs. I've used my device every single night for over a year. I feel it's wasted time when it could be delivering actually good, easy to use, lung healing medications.
I would even sit for a short period of time with a nebulizer if the liquid had some serious healing effects.
If one can vape nicotine, there MUST be some other drug that will take advantage of such a device . Many come with prefilled, sealed capsules. Surely we should be able to get medicines delivered that way.

[@tanthiennguyen9308]

Water